Pillstats
Rx only · Tablet · Oral

Clobazam

Brands: Onfi · Clobazam

11 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US22 NDCs
11 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC—
RxCUI (US)—
US makers11 labelers
Packages39
DEA / ScheduleCIV

US acquisition costNADAC · per unit

Average across 17 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.81$3.61$5.42$7.23Dec 2025Mar 2026Jun 2026
$5.587
Latest avg · Jun 17, 2026
-11%
Since Dec 17, 2025
11
Active US suppliers
51%
Top-2 supplier share*

Who makes it11 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Micro Labs Limitedunknown11SUPPLYING
Ascend Laboratories, LLCunknown9SUPPLYING
Camber Pharmaceuticals, Inc.unknown4SUPPLYING
Upsher-Smith Laboratories, LLCunknown2SUPPLYING
Golden State Medical Supply, Inc.unknown2SUPPLYING
Novadoz Pharmaceuticals LLCunknown2SUPPLYING
Lupin Pharmaceuticals,Inc.unknown2SUPPLYING
NorthStar RxLLCunknown2SUPPLYING
Amneal Pharmaceuticals LLCunknown2SUPPLYING
Lundbeck Pharmaceuticals LLCunknown2SUPPLYING
American Health Packagingunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.